WO2012134188A3 - 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 - Google Patents
신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 Download PDFInfo
- Publication number
- WO2012134188A3 WO2012134188A3 PCT/KR2012/002314 KR2012002314W WO2012134188A3 WO 2012134188 A3 WO2012134188 A3 WO 2012134188A3 KR 2012002314 W KR2012002314 W KR 2012002314W WO 2012134188 A3 WO2012134188 A3 WO 2012134188A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- novel oxazolidinone
- oxazolidinone derivative
- chemical formula
- present
- composition containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Abstract
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2012237067A AU2012237067B2 (en) | 2011-03-30 | 2012-03-29 | Novel oxazolidinone derivative and medical composition containing same |
CA2831799A CA2831799A1 (en) | 2011-03-30 | 2012-03-29 | Oxazolidinone derivative and pharmaceutical composition including the same |
CN201280016771.9A CN103476772B (zh) | 2011-03-30 | 2012-03-29 | 噁唑烷酮衍生物及包含该噁唑烷酮衍生物的药物组合物 |
RU2013143800A RU2617408C2 (ru) | 2011-03-30 | 2012-03-29 | Новое производное оксазолидинона и включающая его фармацевтическая композиция |
EP12764499.5A EP2692727A4 (en) | 2011-03-30 | 2012-03-29 | NEW OXAZOLIDINONE DERIVATIVE AND MEDICAL COMPOSITION THEREWITH |
BR112013024497-6A BR112013024497A2 (ko) | 2011-03-30 | 2012-03-29 | Novel oxazolidinone derivatives and pharmaceutical compositions containing them |
MX2013011272A MX337409B (es) | 2011-03-30 | 2012-03-29 | Derivado de oxazolidinona novedoso y composicion farmaceutica que incluye el mismo. |
JP2014502469A JP6072764B2 (ja) | 2011-03-30 | 2012-03-29 | 新規なオキサゾリジノン誘導体およびそれを含む医薬組成物 |
EP18167465.6A EP3372598A1 (en) | 2011-03-30 | 2012-03-29 | Novel oxazolidinone derivative and pharmaceutical composition including the same |
US14/008,702 US8846669B2 (en) | 2011-03-30 | 2012-03-29 | Oxazolidinone derivative and medical composition containing same |
ZA2013/07216A ZA201307216B (en) | 2011-03-30 | 2013-09-26 | Novel oxazolidinone derivative and pharmaceutical composition including the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110028559A KR101653570B1 (ko) | 2011-03-30 | 2011-03-30 | 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 |
KR10-2011-0028559 | 2011-03-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012134188A2 WO2012134188A2 (ko) | 2012-10-04 |
WO2012134188A3 true WO2012134188A3 (ko) | 2013-01-10 |
Family
ID=46932138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/002314 WO2012134188A2 (ko) | 2011-03-30 | 2012-03-29 | 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 |
Country Status (12)
Country | Link |
---|---|
US (1) | US8846669B2 (ko) |
EP (2) | EP3372598A1 (ko) |
JP (1) | JP6072764B2 (ko) |
KR (1) | KR101653570B1 (ko) |
CN (1) | CN103476772B (ko) |
AU (1) | AU2012237067B2 (ko) |
BR (1) | BR112013024497A2 (ko) |
CA (1) | CA2831799A1 (ko) |
MX (1) | MX337409B (ko) |
RU (1) | RU2617408C2 (ko) |
WO (1) | WO2012134188A2 (ko) |
ZA (1) | ZA201307216B (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104774198A (zh) * | 2014-01-15 | 2015-07-15 | 上海美迪西生物医药有限公司 | 一种新噁唑烷酮类化合物及其制备方法 |
CN106928214A (zh) * | 2014-09-17 | 2017-07-07 | 博瑞生物医药(苏州)股份有限公司 | 一种噁唑烷酮类化合物及其中间体的制备方法 |
US9802927B2 (en) | 2015-06-10 | 2017-10-31 | Denali Therapeutics, Inc. | Oxadiazine compounds and methods of use thereof |
CN106045934A (zh) * | 2015-10-27 | 2016-10-26 | 博瑞生物医药(苏州)股份有限公司 | 一种合成泰地唑胺的中间体的晶型 |
CN107722056A (zh) * | 2017-10-31 | 2018-02-23 | 重庆华邦胜凯制药有限公司 | 磷酸特地唑胺的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080077828A (ko) * | 2007-02-21 | 2008-08-26 | 주식회사 레고켐 바이오사이언스 | 아미독심 또는 하이드록사마이드 기를 가지는 신규한옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 |
KR101023174B1 (ko) * | 2008-09-24 | 2011-03-18 | 주식회사 레고켐 바이오사이언스 | 사이클릭 아미독심 또는 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES8506659A1 (es) | 1983-06-07 | 1985-08-01 | Du Pont | Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno. |
BR0111280A (pt) * | 2000-06-05 | 2003-06-10 | Dong A Pharm Co Ltd | Novos derivados de oxazolidinona e um processo para a preparação dos mesmos |
KR100731469B1 (ko) * | 2000-06-05 | 2007-06-21 | 동아제약주식회사 | 피리딘 고리를 포함하는 옥사졸리디논 유도체 및 그의제조방법 |
GB0229522D0 (en) * | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
GB0229521D0 (en) * | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
TW200500360A (en) * | 2003-03-01 | 2005-01-01 | Astrazeneca Ab | Hydroxymethyl compounds |
KR100854211B1 (ko) * | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
JP2008500319A (ja) * | 2004-05-25 | 2008-01-10 | アストラゼネカ アクチボラグ | 細菌感染症の治療のためのmao阻害剤としての3−(4−(2−ジヒドロイソオキサゾール−3−イルピリジン−5−イル)フェニル−5−トリアゾール−1−イルメチルオキサゾリジン−2−オン誘導体 |
US20100286211A1 (en) * | 2004-10-08 | 2010-11-11 | Biswajit Das | Oxazolidinone derivatives as antimicrobials |
US20090018123A1 (en) * | 2005-06-20 | 2009-01-15 | Milind D Sindkhedkar | Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation |
KR100870432B1 (ko) | 2007-04-18 | 2008-11-25 | 주식회사 하이닉스반도체 | 트리밍 테스트모드 및 노말 테스트모드를 갖는반도체메모리소자 |
KR101037051B1 (ko) * | 2009-07-08 | 2011-05-26 | 주식회사 레고켐 바이오사이언스 | (s)-5-클로로-n-((3-(4-(5,6-다이하이드로-4h-1,2,4-옥사다이아진-3-일)페닐)-2-옥소옥사졸리딘-5-일)메틸)싸이오펜-2-카르복사미드 유도체의 제조방법 |
-
2011
- 2011-03-30 KR KR1020110028559A patent/KR101653570B1/ko active IP Right Grant
-
2012
- 2012-03-29 AU AU2012237067A patent/AU2012237067B2/en not_active Ceased
- 2012-03-29 BR BR112013024497-6A patent/BR112013024497A2/ko not_active IP Right Cessation
- 2012-03-29 CN CN201280016771.9A patent/CN103476772B/zh not_active Expired - Fee Related
- 2012-03-29 WO PCT/KR2012/002314 patent/WO2012134188A2/ko active Application Filing
- 2012-03-29 JP JP2014502469A patent/JP6072764B2/ja not_active Expired - Fee Related
- 2012-03-29 EP EP18167465.6A patent/EP3372598A1/en not_active Withdrawn
- 2012-03-29 EP EP12764499.5A patent/EP2692727A4/en not_active Ceased
- 2012-03-29 RU RU2013143800A patent/RU2617408C2/ru not_active IP Right Cessation
- 2012-03-29 MX MX2013011272A patent/MX337409B/es active IP Right Grant
- 2012-03-29 CA CA2831799A patent/CA2831799A1/en not_active Abandoned
- 2012-03-29 US US14/008,702 patent/US8846669B2/en not_active Expired - Fee Related
-
2013
- 2013-09-26 ZA ZA2013/07216A patent/ZA201307216B/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080077828A (ko) * | 2007-02-21 | 2008-08-26 | 주식회사 레고켐 바이오사이언스 | 아미독심 또는 하이드록사마이드 기를 가지는 신규한옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 |
KR101023174B1 (ko) * | 2008-09-24 | 2011-03-18 | 주식회사 레고켐 바이오사이언스 | 사이클릭 아미독심 또는 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 |
Also Published As
Publication number | Publication date |
---|---|
EP3372598A1 (en) | 2018-09-12 |
KR101653570B1 (ko) | 2016-09-02 |
EP2692727A4 (en) | 2014-10-15 |
AU2012237067A1 (en) | 2013-10-03 |
CN103476772B (zh) | 2016-03-30 |
AU2012237067B2 (en) | 2016-07-28 |
ZA201307216B (en) | 2014-12-23 |
US8846669B2 (en) | 2014-09-30 |
EP2692727A2 (en) | 2014-02-05 |
CN103476772A (zh) | 2013-12-25 |
JP2014510751A (ja) | 2014-05-01 |
US20140179691A1 (en) | 2014-06-26 |
BR112013024497A2 (ko) | 2018-06-26 |
CA2831799A1 (en) | 2012-10-04 |
WO2012134188A2 (ko) | 2012-10-04 |
MX337409B (es) | 2016-03-02 |
KR20120110600A (ko) | 2012-10-10 |
MX2013011272A (es) | 2014-03-21 |
RU2013143800A (ru) | 2015-05-10 |
JP6072764B2 (ja) | 2017-02-01 |
RU2617408C2 (ru) | 2017-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012134184A3 (ko) | 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물 | |
EP2662353A3 (en) | Antibacterial agents | |
WO2010032147A3 (en) | Hydroxamic acid derivatives useful as antibacterial agents | |
NZ593892A (en) | Antibiotic compositions for the treatment of gram negative infections | |
WO2014209841A3 (en) | Compounds for treating spinal muscular atrophy | |
EP3216798A3 (en) | Ketolide compounds | |
GEP20156370B (en) | Fluoro-pyridinone derivatives useful as antibacterial agents | |
EP2295402A3 (en) | Antibacterial agents | |
WO2007069020A3 (en) | N-hydroxyamide derivatives possessing antibacterial activity | |
WO2012134188A3 (ko) | 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 | |
WO2010047737A3 (en) | Antimicrobial indoline compounds for treatment of bacterial infections | |
NZ594675A (en) | Actagardine derivatives | |
MX2020000576A (es) | Compuestos quimicos. | |
NZ596628A (en) | Ketolide compounds having antimicrobial activity | |
WO2013106761A3 (en) | Antimicrobial agents | |
NZ740051A (en) | Tetracycline compounds | |
WO2014022382A3 (en) | Antibacterial protein kinase inhibitors | |
EP4272831A3 (en) | Diazabicyclooctanones as inhibitors of serine beta-lactamases | |
WO2010036000A3 (en) | Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof | |
WO2009116044A3 (en) | Guanine nucleotide derivatives for treating bacterial infections | |
WO2008028805A3 (de) | Verwendung einer pharmazeutischen zusammensetzung enthaltend ein anticholinergikum zur abtötung von mikroorganismen und zur behandlung von atemwegsinfektionen | |
MX2021003485A (es) | Derivados de indano para uso en el tratamiento de infeccion bacteriana. | |
WO2012026988A3 (en) | Dendrimeric peptides, pharmaceutical compositions and methods of using the same | |
WO2009077485A3 (en) | 1(2)h-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents | |
WO2010012381A8 (en) | Streptospirole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201280016771.9 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12764499 Country of ref document: EP Kind code of ref document: A2 |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2014502469 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2831799 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2013/011272 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2012237067 Country of ref document: AU Date of ref document: 20120329 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2013143800 Country of ref document: RU Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14008702 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112013024497 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112013024497 Country of ref document: BR Kind code of ref document: A2 Effective date: 20130924 |